-
EKOS Corporation addresses treatment for pulmonary embolism
- May 3, 2012
-
Pradaxa ranks first among drugs most often reported to the FDA
- Jun 7, 2012
-
Soccer moms taking Adderall to get through daily stress
- Jun 27, 2012
-
FDA advisory panel under scrutiny for voting against Yaz® recall
- Mar 21, 2012
-
Study shows increased heart attack risk with Pradaxa® use
- Feb 20, 2012
-
Johnson & Johnson faces new marketing investigations
- Aug 7, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
Belviq Zocor Avandia deep vein thrombosis Products internal bleeding ADHD lorcaserin Fosamax prescription drugs pulmonary embolism Technology venous thromboembolism HIV test blood clots Fen-Phen Actos blood thinners D.C. Eliquis Bayer Lexapro pulomonary embolism dabigatran regorafenib breast cancer Nexavar TVM colon cancer yo